Harrow (HROW) Change in Account Payables (2010 - 2018)
Harrow's (HROW) quarterly Change in Account Payables came in at $64000.0 in Q3 2018, up 264.1% quarter-over-quarter from -$39000.0 in Q2 2018.
Harrow (HROW) Change in Account Payables (2010 - 2018) Analysis & Trends
Harrow's Change in Account Payables history runs 8 years deep, the most recent figure standing at $64000.0 for Q3 2018.
- On a quarterly basis, Change in Account Payables changed N/A year-over-year to $64000.0 in Q3 2018; TTM through Sep 2018 was $90000.0, a 195.74% increase from a year earlier, with the FY2017 full-year figure at -$62000.0, down 338.46% from the prior year.
- Change in Account Payables rose to $64000.0 in Q3 2018 per HROW's latest filing, from -$39000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $64000.0 in Q3 2018 and bottomed at -$83000.0 in Q1 2017.
- The 5-year median for Change in Account Payables is $500.0 (2014), against an average of $428.57.
- Biggest YoY gain for Change in Account Payables was 4500.0% in 2015; the steepest drop was 2700.0% in 2015.
- Year by year, Change in Account Payables stood at -$1000.0 in 2014, then surged by 4500.0% to $44000.0 in 2015, then slumped by 125.0% to -$11000.0 in 2016, then soared by 290.91% to $21000.0 in 2017, then jumped by 204.76% to $64000.0 in 2018.
- Per Business Quant, the three latest HROW Change in Account Payables figures stand at $64000.0 (Q3 2018), -$39000.0 (Q2 2018), and $44000.0 (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 64,000.00 |
| Sep 30, 2018 | 64,000.00 |
| Jun 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -39,000.00 |
| Mar 31, 2018 | 44,000.00 |
| Mar 31, 2018 | 44,000.00 |
| Dec 31, 2017 | 21,000.00 |
| Dec 31, 2017 | 21,000.00 |
| Mar 31, 2017 | -83,000.00 |
| Mar 31, 2017 | -83,000.00 |
| Sep 30, 2016 | -11,000.00 |
| Sep 30, 2016 | -11,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Mar 31, 2016 | -15,000.00 |
| Mar 31, 2016 | -15,000.00 |
| Dec 31, 2015 | 44,000.00 |
| Dec 31, 2015 | 44,000.00 |
| Sep 30, 2015 | -52,000.00 |
| Sep 30, 2015 | -52,000.00 |